Susceptibility genes for the development of SLE during treatment of IBD

Dataset ID Technology Samples
EGAD00001000670 Illumina HiSeq 2000 15

Dataset Description

A potential and very serious side effect of treating IBD with antiTNFa therapies (the currentgold standard) is the development of systemic lupus erythematosis (SLE). This side effect israre and unpredictable. Out of several thousand cases having received treatment, theUniversity of Calgary have accumulated 12 individuals with full phenotyping and novelserological antibody discovery panel data. We propose to exome sequence these samples inan effort to identify rare highly-penetrant variants that could be underlying this severephenotype.

Who controls access to this dataset

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:

Contact person: Carl Anderson
Email: ca3 [at] sanger [dot] ac [dot] uk
More details: EGAC00001000111


You don't have access to the download section.